WHITFIELD ROY A

NKTR

WHITFIELD ROY A serves as Director at Nektar Therapeutics (NKTR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$17.1K

Net Position

Net Seller

$17.1K

Companies Traded

NKTR

Active Period

Jun 2023

1 total trades

Most Recent

Sell NKTR

Jun 15, 2023 · $17.1K

WHITFIELD ROY A's Insider Trading at Nektar Therapeutics (NKTR)

Buys

0 · $0.00

Sells

1 · $17.1K

Total Shares Bought

Total Shares Sold

30,000

NKTR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 15, 2023↗	Sell	30,000	$0.57	$17.1K	216,250

Related Insiders

ROBIN HOWARD W

director, officer: President & CEO

NKTRSell · Feb 18, 2026

ROBIN HOWARD W

President & CEO

NKTRSell · Feb 18, 2026

Jonathan Zalevsky

Chief R&D Officer

NKTRSell · Feb 18, 2026

Jonathan Zalevsky

officer: Chief R&D Officer

NKTRSell · Feb 18, 2026

Mark Andrew Wilson

Chief Legal Officer

NKTRSell · Nov 25, 2025

Explore More Insider Trading Data

NKTR Insider Trading Activity

View all insider trades at Nektar Therapeutics

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity